These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16885216)

  • 1. Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.
    Homayoun H; Moghaddam B
    J Neurosci; 2006 Aug; 26(31):8025-39. PubMed ID: 16885216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex.
    Peterson JD; Wolf ME; White FJ
    J Neurosci; 2006 Mar; 26(12):3164-8. PubMed ID: 16554467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.
    Mohila CA; Onn SP
    Cereb Cortex; 2005 Mar; 15(3):262-74. PubMed ID: 15238432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo.
    Onn SP; Grace AA
    J Neurosci; 2000 Mar; 20(6):2332-45. PubMed ID: 10704508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine sensitization is accompanied by an increase in prelimbic cortex activity.
    Aguilar-Rivera MI; Casanova JP; Gatica RI; Quirk GJ; Fuentealba JA
    Neuroscience; 2015 Mar; 288():1-9. PubMed ID: 25542419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptations in medial prefrontal cortex function associated with amphetamine-induced behavioral sensitization.
    Gulley JM; Stanis JJ
    Neuroscience; 2010 Mar; 166(2):615-24. PubMed ID: 20035836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticity and functions of the orbital frontal cortex.
    Kolb B; Pellis S; Robinson TE
    Brain Cogn; 2004 Jun; 55(1):104-15. PubMed ID: 15134846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.
    Belujon P; Jakobowski NL; Dollish HK; Grace AA
    Neuropsychopharmacology; 2016 Jan; 41(2):619-27. PubMed ID: 26129677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction.
    Canales JJ
    Neurobiol Learn Mem; 2005 Mar; 83(2):93-103. PubMed ID: 15721792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
    Fuller JJ; Murray RC; Horner KA
    Neuropharmacology; 2015 Oct; 97():7-17. PubMed ID: 25986696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action-outcome relationships are represented differently by medial prefrontal and orbitofrontal cortex neurons during action execution.
    Simon NW; Wood J; Moghaddam B
    J Neurophysiol; 2015 Dec; 114(6):3374-85. PubMed ID: 26467523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.
    Robinson TE; Kolb B
    J Neurosci; 1997 Nov; 17(21):8491-7. PubMed ID: 9334421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals.
    Tanabe J; Tregellas JR; Dalwani M; Thompson L; Owens E; Crowley T; Banich M
    Biol Psychiatry; 2009 Jan; 65(2):160-4. PubMed ID: 18801475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal separation altered behavior and neuronal spine density without influencing amphetamine sensitization.
    Muhammad A; Kolb B
    Behav Brain Res; 2011 Sep; 223(1):7-16. PubMed ID: 21515311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired DRL 30 performance during amphetamine withdrawal.
    Peterson JD; Wolf ME; White FJ
    Behav Brain Res; 2003 Jul; 143(1):101-8. PubMed ID: 12842301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Amphetamine potentiates muscimol-induced disinhibition of A10 dopaminergic neurons in the rat.
    Overton PG; Lokwan SJ; Berry MS; Clark D
    J Neural Transm (Vienna); 2000; 107(12):1381-91. PubMed ID: 11458991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons.
    McPherson CS; Featherby T; Krstew E; Lawrence AJ
    J Pharmacol Exp Ther; 2007 Dec; 323(3):805-12. PubMed ID: 17878407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid synaptic plasticity of glutamatergic synapses on dopamine neurons in the ventral tegmental area in response to acute amphetamine injection.
    Faleiro LJ; Jones S; Kauer JA
    Neuropsychopharmacology; 2004 Dec; 29(12):2115-25. PubMed ID: 15150533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent gene expression changes in NAc, mPFC, and OFC associated with previous nicotine or amphetamine exposure.
    Mychasiuk R; Muhammad A; Ilnytskyy S; Kolb B
    Behav Brain Res; 2013 Nov; 256():655-61. PubMed ID: 24021241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.